Health Technology · Pharmaceuticals: Major · NSE: SGRL · data 2026-10-09

Shree Ganesh Remedies Ltd.

Health check: Average (5.4/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹678.65

Market cap

₹907 cr

P/E

56.5

P/B

—

ROE

11.5%

ROCE

14.4%

Debt / equity

0.19

Dividend yield

0.00%

1-year return

37.1%

52-week high

₹749.85

52-week low

₹477.05

Operating margin

20.8%

Growth

Revenue (last 12 months)	₹99 cr
Net profit (last 12 months)	₹15 cr
Sales growth, 3 years (yearly)	6.6%
Profit growth, 3 years (yearly)	1.4%

Similar companies

Themis Medicare Limited (THEMISMED) · Bafna Pharmaceuticals Limited (BAFNAPH) · Kilitch Drugs (India) Limited (KILITCH) · Hexagon Nutrition Limited (HEXAGON) · Anuh Pharma Limited (ANUHPHR)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open SGRL in NSE Scanner →